These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 7687130

  • 1. Comparison of the effect of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells.
    Morgan AJ, Murray KJ, Challiss RA.
    Biochem Pharmacol; 1993 Jun 22; 45(12):2373-80. PubMed ID: 7687130
    [Abstract] [Full Text] [Related]

  • 2. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
    Wachtel H.
    J Neural Transm; 1983 Jun 22; 56(2-3):139-52. PubMed ID: 6190991
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE, Hassall GA, Parrott DP.
    Biochem Pharmacol; 1992 Sep 01; 44(5):857-66. PubMed ID: 1326964
    [Abstract] [Full Text] [Related]

  • 4. cAMP decreases steady-state levels of delta-opioid receptor mRNA in NG108-15 cells.
    Gylys KH, Tran N, Magendzo K, Zaki P, Evans CJ.
    Neuroreport; 1997 Jul 07; 8(9-10):2369-72. PubMed ID: 9243642
    [Abstract] [Full Text] [Related]

  • 5. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
    Altiok N, Fredholm BB.
    Neurochem Int; 1992 Sep 07; 21(2):209-13. PubMed ID: 1284620
    [Abstract] [Full Text] [Related]

  • 6. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Gordeladze JO.
    Biosci Rep; 1990 Aug 07; 10(4):375-88. PubMed ID: 2174276
    [Abstract] [Full Text] [Related]

  • 7. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC, Anderson N, Peachell PT.
    Br J Pharmacol; 1997 May 07; 121(2):287-95. PubMed ID: 9154339
    [Abstract] [Full Text] [Related]

  • 8. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R, Pyne NJ, Furman BL.
    Br J Pharmacol; 1995 Aug 07; 115(8):1486-92. PubMed ID: 8564209
    [Abstract] [Full Text] [Related]

  • 9. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M, Fredholm BB, Lerner UH.
    Bone Miner; 1988 Jan 07; 3(3):225-34. PubMed ID: 2462948
    [Abstract] [Full Text] [Related]

  • 10. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y, Endoh M.
    J Cardiovasc Pharmacol; 1992 Jan 07; 20(5):715-22. PubMed ID: 1280732
    [Abstract] [Full Text] [Related]

  • 11. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
    Nicholson D, White TD, Sawynok J.
    Can J Physiol Pharmacol; 1991 Jun 07; 69(6):877-85. PubMed ID: 1717120
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A, Tenor H, Schudt C.
    Br J Pharmacol; 1995 Feb 07; 114(4):821-31. PubMed ID: 7539697
    [Abstract] [Full Text] [Related]

  • 13. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY, Lee GH, Lee MS, Kim HM, Lee JW.
    Life Sci; 2012 Feb 27; 90(9-10):373-80. PubMed ID: 22227470
    [Abstract] [Full Text] [Related]

  • 14. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
    Kim DH, Lerner A.
    Blood; 1998 Oct 01; 92(7):2484-94. PubMed ID: 9746789
    [Abstract] [Full Text] [Related]

  • 15. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
    Wachtel H.
    Psychopharmacology (Berl); 1982 Oct 01; 77(4):309-16. PubMed ID: 6182575
    [Abstract] [Full Text] [Related]

  • 16. Existence of rolipram-sensitive phosphodiesterase in rat megakaryocyte.
    Akaike N, Uneyama H, Kawa K, Yamashita Y.
    Br J Pharmacol; 1993 Aug 01; 109(4):1020-3. PubMed ID: 7691362
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC, Eiger S, Duan DS, Lameh J, Sadée W.
    J Neurochem; 1990 Oct 01; 55(4):1390-6. PubMed ID: 1697894
    [Abstract] [Full Text] [Related]

  • 18. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Van Tine BA, Azizeh BY, Trivedi D, Phelps JR, Houslay MD, Johnson DG, Hruby VJ.
    Endocrinology; 1996 Aug 01; 137(8):3316-22. PubMed ID: 8754757
    [Abstract] [Full Text] [Related]

  • 19. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    Wright IK, Amirchetty-Rao S, Kendall DA.
    Br J Pharmacol; 1994 Aug 01; 112(4):1146-50. PubMed ID: 7524992
    [Abstract] [Full Text] [Related]

  • 20. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
    Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, Magnussen H.
    Am J Physiol; 1994 May 01; 266(5 Pt 1):L536-43. PubMed ID: 7515580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.